HOME >> BIOLOGY >> NEWS
NIAID launches major step in trial of experimental shingles vaccine

On June 17, researchers at NIAID will launch an important next step in a study of an experimental vaccine to prevent shingles (also known as herpes zoster, or just "zoster"). In the so-called Phase III trial, the team will study the vaccine's safety and how well it works to prevent the disease.

Dr. Philip Brunell, an internationally renowned pediatrician and expert on the chickenpox virus, will officially open the trial by rolling up his sleeve to become the first person to be immunized with the experimental vaccine. The NIAID study will test a more potent version of the vaccine used to immunize children against the chickenpox virus. Earlier studies have shown the study vaccine to be safe and well tolerated.

At 68, Dr. Brunell believes strongly in the new vaccine's potential. "After almost 40 years of studying varicella-zoster virus," he said, "it is exciting for me to now be involved in testing this vaccine. Zoster, or shingles, is a very significant concern for those of us over 60, as the chance of getting it increases and the condition is often more severe as we grow older."

Shingles is a major health problem in older adults. Any individual has a 20 percent chance of developing it during his or her lifetime. Of the hundreds of thousands of people in the United States who will be diagnosed with shingles this year, most will be over age 60.

Shingles is caused by the same virus, varicella-zoster (VZV), that causes chickenpox. After a person has had chickenpox, VZV remains in the nerve cells by the spinal cord for life but is usually dormant. If it becomes reactivated, however, it can cause shingles. Early symptoms may include an outbreak of rash or blisters - usually on one side of the body or face - burning, tingling or shooting pain. Although skin symptoms may heal within weeks, the pain (called post-herpetic neuralgia) can be intense, severely debilitating and last for years. Other serious complications, such as blindness or
'"/>

Contact: Ellen O'Donnell
eodonnell@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
15-Jun-1999


Page: 1 2

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID unveils bioterrorism research agenda
3. NIAID takes next genome step
4. NIAID awards grant to rapidly sequence the malaria mosquito genome
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
9. Joslin Diabetes Center launches research section on developmental and stem cell biology
10. NIH launches first center in Nationwide Chemical Genomics Network
11. Biogeosciences.org launches

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2019)... (PRWEB) , ... March 05, 2019 , ... Join this ... how a metadata-driven approach will help data analysts and bioinformaticians focus on data analysis ... unify data that can come from different source systems. Some sources of data include:, ...
(Date:2/27/2019)... ... ... Circulomics is launching the Short Read Eliminator Kit to perform ... , This kit enhances long-read sequencing read lengths by using size selective precipitation ... and recovered with high efficiency. Short DNA up to 25 kb in length are ...
(Date:2/22/2019)... ... 2019 , ... Clean label food is not just another passing trend in ... It is quite common to spot consumers running their index finger across the back ... this label scrutiny. , More than ever, meat and poultry producers are working ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... 14, 2019 , ... ON NOVEMBER 27, 2018, Nova Oculus ... Machine Canada Inc., had been given approval to begin a clinical patient trial ... (AMD). , The previous month, the medical devices bureau of Health Canada had ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... standard solution for preclinical research organizations. It is a low code, GDPR/21 ... systems and facilities, innovative technology-driven automated data capture and seamless data and ...
(Date:3/11/2019)... ... March 11, 2019 , ... In this live webinar, the featured speakers will ... efficiency and experience. Participants will learn how to use the information they have from ... the simple or complex randomization scheme is properly designed and set up to ensure ...
(Date:3/9/2019)... ... March 08, 2019 , ... ... announced the release of their Best Online Master's in Biotechnology Programs for ... curriculum quality, program flexibility, affordability, and graduate outcomes. , In addition to ...
Breaking Biology Technology:
Cached News: